Correlation Between Bionoid Pharma and Arhaus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bionoid Pharma and Arhaus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionoid Pharma and Arhaus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bionoid Pharma and Arhaus Inc, you can compare the effects of market volatilities on Bionoid Pharma and Arhaus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionoid Pharma with a short position of Arhaus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionoid Pharma and Arhaus.

Diversification Opportunities for Bionoid Pharma and Arhaus

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Bionoid and Arhaus is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Bionoid Pharma and Arhaus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arhaus Inc and Bionoid Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionoid Pharma are associated (or correlated) with Arhaus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arhaus Inc has no effect on the direction of Bionoid Pharma i.e., Bionoid Pharma and Arhaus go up and down completely randomly.

Pair Corralation between Bionoid Pharma and Arhaus

Given the investment horizon of 90 days Bionoid Pharma is expected to generate 13.91 times more return on investment than Arhaus. However, Bionoid Pharma is 13.91 times more volatile than Arhaus Inc. It trades about 0.06 of its potential returns per unit of risk. Arhaus Inc is currently generating about 0.0 per unit of risk. If you would invest  100.00  in Bionoid Pharma on October 11, 2024 and sell it today you would lose (74.00) from holding Bionoid Pharma or give up 74.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Bionoid Pharma  vs.  Arhaus Inc

 Performance 
       Timeline  
Bionoid Pharma 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bionoid Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain basic indicators, Bionoid Pharma reported solid returns over the last few months and may actually be approaching a breakup point.
Arhaus Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Arhaus Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's technical indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Bionoid Pharma and Arhaus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bionoid Pharma and Arhaus

The main advantage of trading using opposite Bionoid Pharma and Arhaus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionoid Pharma position performs unexpectedly, Arhaus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arhaus will offset losses from the drop in Arhaus' long position.
The idea behind Bionoid Pharma and Arhaus Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
CEOs Directory
Screen CEOs from public companies around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals